Rebound of Antibiotic Use and Respiratory Infections After Resumption of Normalcy From COVID-19 in Hong Kong
We demonstrated a substantial reduction of antibiotic use during the COVID-19 pandemic, which rebounded in 2023, likely due to increased incidence of respiratory diseases after lifting of public health and social measures. We urged for close monitoring of the antimicrobial resistance pattern of different bacteria due to the inter-connectiveness and global impact of these two pandemics.
Authors
- Enoch K. Hsu (ORCID: https://orcid.org/0000-0002-9163-9218)
- Ting Soo Chow
- KH Kung
- Hong Chen (ORCID: https://orcid.org/0000-0001-8854-2119)
- Edmond Siu-Keung Ma (ORCID: https://orcid.org/0000-0003-3071-6256)
- Albert Ka-Wing Au (ORCID: https://orcid.org/0009-0009-6916-0735)
- Vincent Chow (ORCID: https://orcid.org/0009-0001-6547-9871)
Institutions
- Department of Health (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/idr.s502126
- Citations
- 5
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 6.31